DCAT Week ’17 session looks at emerging pharma market trends

The health of emerging pharmaceutical companies can be assessed, in part, by financing and partnership activity with larger companies, Richard Harrison, Chief Scientific Officer at Clarivate Analytics, told a DCAT Week ’17 audience in a session titled “Emerging Pharma: Market Overview, Project Management and CMC Readiness.”

Read more >

Advancing evidence-based indication prioritization to navigate disease segmentation landscape

Innovation in genomic technologies over the past two decades has ushered in an explosion of new drug targets for drug discovery.

Read more >

Latin American market presents attractive opportunities in innovation and generics, but adaptability is key

The combined populations of the three most populous countries in Latin America – Brazil, Mexico, and Colombia – account for more than 350 million people. Pharmaceutical companies have long sought access to the growing market in Latin America and many have faced difficulties in doing so.

Read more >

Cortellis Deals Landscape: Notable licensing deals of Q1 2017

During the first quarter of 2017, Cortellis Competitive Intelligence added 1,073 new deals as part of its ongoing coverage of pharmaceutical licensing activity.

Read more >

Victories in Huntington’s disease few and far between, but resolve remains undimmed

The HD community has tempered its expectations but not its optimism.

Read more >